Skip to content
Article Rich – Lifestyle
Author:
CASI Pharmaceuticals
CASI Pharmaceuticals Announces First Half 2026 Business and Financial Results
August 14, 2026
CASI Pharmaceuticals Receives the Delisting Decision From the Nasdaq Hearings Panel
March 5, 2026